Quick answer
MCA funders in 2026 underwriting healthcare practices review EHR (Epic, Cerner, Athenahealth, eClinicalWorks) data for patient volume and CPT code mix, insurance payer mix (Medicare, Medicaid, commercial), accounts receivable aging, days sales outstanding (DSO target 30-45 days), and denial rates. Specialty healthcare funders (Medical Capital, Quipt, ProviderFinance) underwrite differently than generic MCA funders, accepting longer A/R cycles and offering A/R-collateralized advances at better pricing.
Full answer
Healthcare practice MCA underwriting overview 2026. Healthcare practices have unique cash flow dynamics due to insurance reimbursement timing (typical 30-90 days from claim submission to payment), payer mix complexity (Medicare/Medicaid vs commercial vs self-pay), denial and rework cycles, and significant fixed costs (provider compensation, equipment, lease). Generic MCA funders treat healthcare like any service business; specialty healthcare lenders underwrite the A/R dynamics specifically and offer better pricing.
EHR systems funders review 2026. (a) Epic — dominant in hospitals and large practices, less common in small practice. (b) Cerner (now Oracle Health) — large enterprise EHR. (c) Athenahealth — popular in independent practices, includes practice management and revenue cycle. (d) eClinicalWorks — mid-market practices. (e) NextGen — mid-market. (f) Greenway Health — mid-market primary care. (g) Practice Fusion — small primary care. (h) AdvancedMD — small to mid-market. (i) DrChrono — specialty practices.
EHR data signals to funders 2026. (a) Patient encounter volume — daily/weekly visit counts. (b) CPT code mix — procedure complexity and reimbursement potential. (c) Payer mix — Medicare/Medicaid vs commercial vs self-pay percentages. (d) Provider productivity — visits per provider per day. (e) New patient vs established patient mix. (f) No-show and cancellation rates. (g) Same-day vs scheduled visit mix.
Insurance reimbursement timing 2026. (a) Medicare — typical 14-30 days payment after clean claim. (b) Medicaid — typical 30-60 days, varies by state. (c) Commercial (BCBS, Aetna, UnitedHealth, Cigna) — typical 14-45 days. (d) Self-pay — at time of service or per practice policy. (e) Workers comp — 60-120 days. (f) Auto liability — 60-180 days. (g) Reimbursement timing varies materially by payer.
Days Sales Outstanding (DSO) signal 2026. (a) DSO = (A/R / annual revenue) × 365. (b) Target DSO 30-45 days for healthy practice. (c) DSO 45-60 days signals collection inefficiency. (d) DSO 60+ days signals significant collection problems. (e) DSO trending up over time flagged. (f) Specialty (Medicare-heavy) DSO lower; Medicaid-heavy DSO higher.
A/R aging analysis 2026. (a) Current (0-30) — healthy. (b) 31-60 — normal, should be majority of A/R. (c) 61-90 — flagged, follow-up needed. (d) 91-120 — denied or appealed claims typically. (e) 120+ — high collection risk. (f) Distribution shifted toward older aging signals collection problems. (g) Insurance vs patient A/R aged separately.
Denial rate and rework analysis 2026. (a) Initial denial rate target under 5%, industry average 8-12%. (b) Final denial rate (after appeals) target under 2%. (c) Denial reasons — coding errors, prior auth missing, eligibility issues, medical necessity. (d) Rework cycle 30-60 days adds to DSO. (e) High denial rate signals revenue cycle management issues. (f) Sophisticated funders review denial rate.
Payer mix considerations 2026. (a) Commercial-heavy practice — higher reimbursement, faster payment, attractive to funders. (b) Medicare-heavy practice — lower reimbursement but reliable, attractive to funders. (c) Medicaid-heavy practice — lowest reimbursement, slowest payment, riskier. (d) Self-pay heavy — highest collection risk (uninsured population). (e) Workers comp/PI heavy — long collection cycles, may require specialty lender.
Specialty-specific underwriting 2026. (a) Primary care — high volume, lower per-visit reimbursement, commercial/Medicare mix. (b) Dental — mix insurance + cash pay, treatment plans, often easier MCA. (c) Cosmetic/aesthetic — cash pay, financing partnerships (CareCredit), excellent for MCA. (d) Veterinary — cash/credit at time of service, excellent for MCA. (e) Mental health — commercial insurance growing, variable reimbursement. (f) Specialty surgery — high reimbursement, complex billing.
Cash pay practice advantages 2026. (a) Cash pay (cosmetic, dental, veterinary, concierge) — payment at time of service. (b) No A/R aging issues. (c) Predictable cash flow. (d) Highest MCA approval rates and best pricing. (e) Practice profile most resembles traditional retail/service business.
Equipment financing vs MCA 2026. (a) Medical equipment (imaging, dental chairs, lab equipment) — better suited to equipment financing (lower APR, longer term). (b) Working capital, payroll, A/R bridge — MCA appropriate. (c) Build-out and acquisition — SBA 7(a) or commercial real estate loan. (d) MCA expensive for medical equipment.
Provider compensation cycle 2026. (a) Physician compensation typically monthly. (b) RVU-based compensation aligns with productivity. (c) Provider draws and salary timing matters for cash flow. (d) Bonus structures and partner distributions seasonal. (e) Funders review provider compensation as fixed cost.
Healthcare-specialty MCA funders 2026. (a) Medical Capital Corporation — A/R-collateralized advances. (b) Quipt — healthcare-focused working capital. (c) ProviderFinance — physician practice financing. (d) Henry Schein Financial Services — dental practice financing. (e) Medical equipment leasing companies often offer working capital adjuncts. (f) Specialty funders better pricing than generic MCA.
Accounts receivable factoring alternative 2026. (a) A/R factoring purchases A/R for immediate cash. (b) Typical advance rate 70-90% of A/R. (c) Factoring fee 2-5% of A/R purchased. (d) Lower effective cost than MCA for A/R-heavy practices. (e) Healthcare A/R factoring specialty (American HealthCare Capital, MedFin). (f) Recourse vs non-recourse factoring distinction important.
CareCredit and patient financing 2026. (a) CareCredit (Synchrony) — patient financing for healthcare services. (b) Practice receives full payment upfront. (c) Patient pays CareCredit over time. (d) Practice pays CareCredit merchant fee (typical 5-15%). (e) Improves practice cash flow vs internal patient financing. (f) Especially common in dental, vet, cosmetic.
HIPAA and data privacy considerations 2026. (a) EHR data sharing with funders requires BAA (Business Associate Agreement). (b) De-identified data preferred. (c) Aggregated practice metrics shared, not patient records. (d) Funders compliant with HIPAA where receiving PHI. (e) Practice attorney review recommended for data sharing arrangements.
Practice acquisition financing 2026. (a) MCA inappropriate for practice acquisition (long-term, high-dollar). (b) SBA 7(a) optimal for practice acquisition. (c) Equipment financing for acquired equipment. (d) Working capital MCA for transition period after acquisition. (e) Goodwill financing through commercial real estate or SBA.
Common healthcare MCA mistakes 2026. (a) Generic MCA when specialty healthcare lender was option. (b) MCA based on gross billings (charges) not net collections. (c) MCA when A/R factoring would have been cheaper. (d) Not enabling EHR data sharing when available. (e) MCA daily payment during slow patient months. (f) Multiple MCAs when single specialty lender could refinance.
Bottom line. MCA funders in 2026 underwriting healthcare practices review EHR (Epic, Cerner, Athenahealth, eClinicalWorks, NextGen, Greenway, Practice Fusion, AdvancedMD, DrChrono) data for patient volume, CPT code mix, payer mix, provider productivity, no-show rates. Insurance reimbursement timing varies by payer — Medicare 14-30 days, commercial 14-45 days, Medicaid 30-60 days, workers comp 60-120 days. DSO target 30-45 days; A/R aging distribution (target majority in 0-60 days) signals collection efficiency. Denial rate target under 5% initial, under 2% final. Payer mix — commercial-heavy or Medicare-heavy practices attractive to funders; Medicaid-heavy or self-pay heavy riskier. Specialty type material — cash pay (cosmetic, dental, vet, concierge) easiest to fund; primary care moderate; specialty surgery complex. Specialty healthcare funders (Medical Capital, Quipt, ProviderFinance, Henry Schein, MedFin) offer better pricing than generic MCA due to A/R-collateralized structure and healthcare A/R factoring (advance 70-90% of A/R, fee 2-5%) lower effective cost. CareCredit and patient financing improve cash flow vs internal patient financing. Medical equipment better suited to equipment financing not MCA; practice acquisition better suited to SBA 7(a). HIPAA BAA required for EHR data sharing with funders. Common mistakes — generic MCA when specialty available, MCA based on charges not collections, MCA when factoring cheaper, no EHR integration. Healthcare-specialty underwriting expertise materially affects pricing and approval.
Related questions
- MCA restaurant R365 POS integration detailed
- MCA ecommerce Shopify Stripe Amazon payout detailed
- MCA multi-location funding strategy detailed
- MCA merchant funding stack strategy detailed
Methodology. Fundnode is an independent funding-platform that scores merchants against our 100-funder database. We earn referral fees from funders when merchants apply via Fundnode. Editorial rankings and answers are independent of fee structure. Updated 2026-06-25.